Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
ddhCTP and the Next Wave of Antiviral Design
2026-09-11
A mechanistic and translational perspective on ddhCTP as a flavivirus-focused RNA virus replication inhibitor, and on how new viperin–nsp8 biology expands antiviral drug development beyond nucleotide chain termination.
-
Aligned Silk Fibroin–Ce6 Films for Infected Wounds
2026-09-11
The reference study engineered an aligned silk fibroin electrospun film bearing Chlorin e6 (Ce6) to combine directional cell guidance with near-infrared photodynamic antibacterial therapy. Its findings indicate that the scaffold can generate reactive oxygen species against Staphylococcus aureus while supporting hemocompatibility, cell growth, and later-stage M2 macrophage polarization during wound repair.
-
SU6656 Src Tyrosine Kinases Inhibitor Workflows
2026-09-10
SU6656 links Src-pathway interrogation with practical workflows for megakaryocyte polyploidization, platelet production, and radiation-response studies. This guide separates evidence-supported applications from testable extensions, with executable setup parameters and troubleshooting strategies.
-
NU7441: Designing Rigorous DNA-PK Assays
2026-09-10
NU7441, also known as KU-57788, is a selective DNA-PK probe for DNA repair research and oncology research. This guide focuses on assay design, orthogonal validation, exposure control, and interpretation rather than repeating a basic product overview.
-
HyperFusion high-fidelity DNA polymerase Workflow
2026-09-09
Build more reliable cloning, genotyping, and sequencing workflows around a proofreading DNA polymerase engineered for speed, accuracy, GC-rich targets, and long amplicons. This practical guide translates findings from C. elegans neurodegeneration research into assay design, reaction setup, optimization, and troubleshooting decisions.
-
GTP Solution (100 mM): From Stock to Study
2026-09-09
GTP Solution (100 mM) is more than an IVT input: it is a controllable nucleotide variable linking RNA synthesis, assay integrity, and translational mRNA research. This guide explains how to evaluate Guanosine-5'-triphosphate quality from stock handling through p21 mRNA-LNP experiments.
-
Idoxuridine Workflows for Viral DNA Research
2026-09-08
Idoxuridine, also known as 5-iodo-2'-deoxyuridine, supports controlled studies of viral DNA synthesis inhibition and replication-dependent antiviral activity. This practical guide covers stock preparation, time-of-addition experiments, orthogonal readouts, and troubleshooting for cell-based antiviral workflows.
-
Dimethyloxalylglycine (DMOG) Use Guide
2026-09-08
Dimethyloxalylglycine (DMOG), SKU A4506, provides a cell-permeable way to investigate pharmacologic hypoxia-inducible factor stabilization and related oxygen-sensing responses. It is intended for controlled laboratory research, not diagnostic, therapeutic, or clinical use, and the available product information should not be treated as a substitute for model-specific optimization.
-
Hoechst 33342 for Senescence Assay Design
2026-09-07
Discover how Hoechst 33342 nuclear stain can strengthen live-cell, fixed-cell, microscopy, and flow cytometry workflows for dermal fibroblast senescence research. This guide translates mitochondrial-quality findings into practical nuclear-counting, segmentation, and assay-normalization decisions.
-
2-NBDG: From Glucose Uptake to Translational Insight
2026-09-07
2-NBDG is more than a fluorescent endpoint: it is a practical bridge between transporter activity, intracellular glucose handling, and translational hypothesis testing. This article connects the mechanistic action of 2-NBDG with recent evidence that araucarene diterpenes promote glucose uptake and pancreatic β-cell regeneration in zebrafish, while outlining assay design, competitive positioning, limitations, and strategies for diabetes and cancer metabolism research.
-
LG 101506 for RXR Signaling Research
2026-09-05
LG 101506 provides a practical small-molecule entry point for dissecting RXR-dependent transcription, differentiation, apoptosis, and metabolism regulation. This workflow connects RXR assays with the RBMS1–B4GALT1–PD-L1 biology reported in triple-negative breast cancer while clearly separating established evidence from hypothesis-generating applications.
-
ATF4-H2S Protection in Doxorubicin Cardiotoxicity
2026-09-04
This bioRxiv preprint identifies a KLF16–ATF4–CSE–H2S pathway that limits oxidative stress and apoptosis during doxorubicin-induced cardiomyopathy. Using cardiac genetic models, AAV9-mediated overexpression, transcriptomics, and transcriptional assays, the study positions ATF4 as a mechanistic regulator of anthracycline-associated cardiac injury while highlighting the need for validation beyond preclinical systems.
-
Azithromycin Workflows for Infection Research
2026-09-04
Build more reproducible bacterial infection research and resistance screens with a solvent-aware, QC-centered Azithromycin workflow. The same strategy also supports trypanosomosis animal model planning, host-cell readouts, and impurity monitoring without confusing exploratory assay conditions with validated specifications.
-
Caged Bioluminescent Probe for Immunoproteasome Activity
2026-09-03
Loy and Trader present a protocol for synthesizing and applying a cleavable, immunoproteasome-selective bioluminescent probe. The workflow combines an iCP-recognition peptide with aminoluciferin-based luminescence to support activity measurements in cells, plate-reader assays, and a tissue-mimicking matrix.
-
Type III Collagen Restricts Breast Cancer Progression
2026-09-02
This study identifies type III collagen (Col3) as a tumor-restrictive component of the breast cancer microenvironment rather than simply a marker of stromal abundance. By combining fibroblast-derived matrices, patient biopsy analysis, TCGA bioinformatics, 3D culture, and mouse models, the authors connect higher Col3 relative to type I collagen with less aggressive disease and reduced metastatic burden.